SEC Company Response from CYTRX CORP (LADX) (CIK 0000799698) (LADX) — Mar 23, 2022

CYTRX CORP (LADX) (CIK 0000799698)
Date: March 23, 2022 · CIK: 0000799698 · Accession: 0001493152-22-007564

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-258453

Date

March 23, 2022

Author

Chief

Form

CORRESP

Company

CYTRX CORP (LADX) (CIK 0000799698)

Letter

CytRx Corporation

San Vicente Boulevard, Suite 650

Los Angeles, California 90049

March 23, 2022

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

Securities and Exchange Commission

Washington, D.C. 20549

Re: CytRx Corporation

Registration Statement on Form S-1, as amended

Initially filed on August 4, 2021, as amended on March 23, 2022

File No. 333-258453 (the “Registration Statement”)

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, CytRx Corporation (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement, as amended, so that it may become effective at 4:00 p.m., Eastern Time, on March 25, 2022, or as soon thereafter as practicable.

Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.

Very
truly yours,
CytRx
Corporation

Show Raw Text

CORRESP
1
filename1.htm

CytRx
Corporation

11726
San Vicente Boulevard, Suite 650

Los
Angeles, California 90049

March
23, 2022

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

Office
of Life Sciences

Securities
and Exchange Commission

Washington,
D.C. 20549

    Re:
    CytRx
    Corporation

    Registration
    Statement on Form S-1, as amended

    Initially
    filed on August 4, 2021, as amended on March 23, 2022

    File
    No. 333-258453 (the “Registration Statement”)

    Request
    for Acceleration

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under
the Securities Act of 1933, as amended, CytRx Corporation (the “Company”) hereby respectfully requests acceleration
of the effective date of the Registration Statement, as amended, so that it may become effective at 4:00 p.m., Eastern Time, on March
25, 2022, or as soon thereafter as practicable.

Should
any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes
and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.

    Very
    truly yours,

    CytRx
    Corporation

    By:

    /s/
    Dr. Stephen Snowdy

    Dr.
    Stephen Snowdy

    Chief
    Executive Officer

    cc:
    Rick
    A. Werner, Esq., Haynes and Boone, LLP

SecProbe.io